Piras, L.; Zuccanti, M.; Russo, P.; Riccio, F.; Agresti, A.; Lustri, C.; Dardani, D.; Ferrera, A.; Fiorentini, V.; Tocci, G.;
et al. Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall. Int. J. Mol. Sci. 2024, 25, 2502.
https://doi.org/10.3390/ijms25052502
AMA Style
Piras L, Zuccanti M, Russo P, Riccio F, Agresti A, Lustri C, Dardani D, Ferrera A, Fiorentini V, Tocci G,
et al. Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall. International Journal of Molecular Sciences. 2024; 25(5):2502.
https://doi.org/10.3390/ijms25052502
Chicago/Turabian Style
Piras, Linda, Michela Zuccanti, Paola Russo, Francesca Riccio, Antonio Agresti, Camilla Lustri, Domenico Dardani, Armando Ferrera, Vincenzo Fiorentini, Giuliano Tocci,
and et al. 2024. "Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall" International Journal of Molecular Sciences 25, no. 5: 2502.
https://doi.org/10.3390/ijms25052502
APA Style
Piras, L., Zuccanti, M., Russo, P., Riccio, F., Agresti, A., Lustri, C., Dardani, D., Ferrera, A., Fiorentini, V., Tocci, G., Tini Melato, G., Volpe, M., Barbato, E., & Battistoni, A.
(2024). Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall. International Journal of Molecular Sciences, 25(5), 2502.
https://doi.org/10.3390/ijms25052502
